{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:52:00Z","timestamp":1784803920376,"version":"3.55.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"National Institute of Health","award":["UG3 TR003288"],"award-info":[{"award-number":["UG3 TR003288"]}]},{"name":"National Institute of Health","award":["UG3TR002158"],"award-info":[{"award-number":["UG3TR002158"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Shiga toxin (Stx) causes significant renal microvascular injury and kidney failure in the pediatric population, and an effective targeted therapy has yet to be demonstrated. Here we established a human kidney microvascular endothelial cell line for the study of Stx mediated injuries with respect to their morphologic, phenotypic, and transcriptional changes, and modeled Stx induced thrombotic microangiopathy (TMA) in flow-mediated 3D microvessels. Distinct from other endothelial cell lines, both isolated primary and immortalized human kidney microvascular endothelial cells demonstrate robust cell-surface expression of the Stx receptor Gb3, and concomitant dose-dependent toxicity to Stx, with significant contributions from caspase-dependent cell death. Use of a glucosylceramide synthase inhibitor (GCSi) to target disruption of the synthetic pathway of Gb3 resulted in remarkable protection of kidney microvascular cells from Stx injury, shown in both cellular morphologies, caspase activation and transcriptional analysis from RNA sequencing. Importantly, these findings are recapitulated in 3D engineered kidney microvessels under flow. Moreover, whole blood perfusion through Stx-treated microvessels led to marked platelet binding on the vessel wall, which was significantly reduced with the treatment of GCSi. These results validate the feasibility and utility of a bioengineered ex vivo human microvascular model under flow to recapitulate relevant blood-endothelial interactions in STEC-HUS. The profound protection afforded by GCSi demonstrates a preclinical opportunity for investigation in human tissue approximating physiologic conditions. Moreover, this work provides a broad foundation for novel investigation into TMA injury pathogenesis and treatment.<\/jats:p>\n               <jats:p>Insight Box: Shiga toxin (Stx) causes endothelial injury that results in significant morbidity and mortality in the pediatric population, with no effective targeted therapy. This paper utilizes human kidney microvascular cells to examine Stx mediated cell death in both 2D culture and flow-mediated 3D microvessels, with injured microvessels also developing marked platelet binding and thrombi formation when perfused with blood, consistent with the clinical picture of HUS. This injury is abrogated with a small molecule inhibitor targeting the synthetic pathway of the Shiga toxin receptor. Our findings shed light onto Stx-induced vascular injuries and pave a way for broad investigation into thrombotic microangiopathies.<\/jats:p>","DOI":"10.1093\/intbio\/zyae001","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T16:58:51Z","timestamp":1706115531000},"source":"Crossref","is-referenced-by-count":2,"title":["Modeling Shiga toxin-induced human renal-specific microvascular injury"],"prefix":"10.1093","volume":"16","author":[{"given":"Russell","family":"Whelan","sequence":"first","affiliation":[{"name":"University of Washington Department of Bioengineering, , Seattle, WA, USA"},{"name":"University of Washington Kidney Research Institute, , Seattle, WA, USA"},{"name":"University of Colorado Department of Pediatrics, , Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lih","sequence":"additional","affiliation":[{"name":"University of Washington Department of Bioengineering, , Seattle, WA, USA"},{"name":"University of Washington Kidney Research Institute, , Seattle, WA, USA"},{"name":"University of Washington Institute of Stem Cell and Regenerative Medicine, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xue","sequence":"additional","affiliation":[{"name":"University of Washington Department of Bioengineering, , Seattle, WA, USA"},{"name":"University of Washington Kidney Research Institute, , Seattle, WA, USA"},{"name":"University of Washington Institute of Stem Cell and Regenerative Medicine, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Himmelfarb","sequence":"additional","affiliation":[{"name":"University of Washington Department of Bioengineering, , Seattle, WA, USA"},{"name":"University of Washington Kidney Research Institute, , Seattle, WA, USA"},{"name":"University of Washington Department of Medicine, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2723-9022","authenticated-orcid":false,"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[{"name":"University of Washington Department of Bioengineering, , Seattle, WA, USA"},{"name":"University of Washington Kidney Research Institute, , Seattle, WA, USA"},{"name":"University of Washington Institute of Stem Cell and Regenerative Medicine, , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"2024012416584404600_ref1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"2024012416584404600_ref2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024012416584404600_ref3","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","article-title":"Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)","volume":"23","author":"Scheiring","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"2024012416584404600_ref4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J Immunol"},{"key":"2024012416584404600_ref5","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"2024012416584404600_ref6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","article-title":"Endothelium structure and function in kidney health and disease","volume":"15","author":"Jourde-Chiche","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2024012416584404600_ref7","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/toxins7051467","article-title":"Do the a subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?","volume":"7","author":"Basu","year":"2015","journal-title":"Toxins (Basel)"},{"key":"2024012416584404600_ref8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/toxins12020067","article-title":"Shiga toxin-associated hemolytic uremic syndrome: a narrative review","volume":"12","author":"Joseph","year":"2020","journal-title":"Toxins (Basel)"},{"key":"2024012416584404600_ref9","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00467-017-3876-0","article-title":"Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS)","volume":"33","author":"Exeni","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"2024012416584404600_ref10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pcl.2018.09.011","article-title":"Hemolytic uremic syndrome","volume":"66","author":"Cody","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"2024012416584404600_ref11","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.614963","article-title":"Role of recent therapeutic applications and the infection strategies of Shiga toxin-producing Escherichia coli","volume":"11","author":"Hwang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2024012416584404600_ref12","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1074\/jbc.M600057200","article-title":"Targeted disruption of Gb3\/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins","volume":"281","author":"Okuda","year":"2006","journal-title":"J Biol Chem"},{"key":"2024012416584404600_ref13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00467-002-1025-9","article-title":"Shigatoxin-1 binding and receptor expression in human kidneys do not change with age","volume":"18","author":"Ergonul","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"2024012416584404600_ref14","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9102157","article-title":"The Shiga toxin receptor globotriaosylceramide as therapeutic target in Shiga toxin E. coli mediated HUS","volume":"9","author":"Feitz","year":"2021","journal-title":"Microorganisms"},{"key":"2024012416584404600_ref15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1203\/PDR.0b013e318211dd57","article-title":"A glucosylceramide synthase inhibitor protects rats against the cytotoxic effects of Shiga toxin 2","volume":"69","author":"Silberstein","year":"2011","journal-title":"Pediatr Res"},{"key":"2024012416584404600_ref16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41390-021-01622-3","article-title":"Eliglustat prevents Shiga toxin 2 cytotoxic effects in human renal tubular epithelial cells","volume":"91","author":"S\u00e1nchez","year":"2021","journal-title":"Pediatr Res"},{"key":"2024012416584404600_ref17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4014\/jmb.1803.03012","article-title":"Experimental in vivo models of bacterial Shiga toxin-associated hemolytic uremic syndrome","volume":"28","author":"Jeong","year":"2018","journal-title":"J Microbiol Biotechnol"},{"key":"2024012416584404600_ref18","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1681\/ASN.2006050419","article-title":"A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease","volume":"17","author":"Keepers","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2024012416584404600_ref19","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1681\/ASN.2015070747","article-title":"A novel three-dimensional human peritubular microvascular system","volume":"27","author":"Ligresti","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2024012416584404600_ref20","doi-asserted-by":"crossref","first-page":"15484","DOI":"10.1016\/S0021-9258(18)82282-7","article-title":"Endothelial heterogeneity in Shiga toxin receptors and responses","volume":"268","author":"Obrig","year":"1993","journal-title":"J Biol Chem"},{"key":"2024012416584404600_ref21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.micpath.2003.11.004","article-title":"Escherichia coli Shiga toxin 1 and TNF-\u03b1 induce cytokine release by human cerebral microvascular endothelial cells","volume":"36","author":"Eisenhauer","year":"2004","journal-title":"Microb Pathog"},{"key":"2024012416584404600_ref22","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1128\/IAI.71.5.2724-2735.2003","article-title":"Rapid apoptosis induced by Shiga toxin in HeLa cells","volume":"71","author":"Fujii","year":"2003","journal-title":"Infect Immun"},{"key":"2024012416584404600_ref23","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/IAI.71.3.1497-1504.2003","article-title":"Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells","volume":"71","author":"Smith","year":"2003","journal-title":"Infect Immun"},{"key":"2024012416584404600_ref24","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1128\/IAI.02213-14","article-title":"DAP1, a negative regulator of autophagy, controls SubAB-mediated apoptosis and autophagy","volume":"82","author":"Yahiro","year":"2014","journal-title":"Infect Immun"},{"key":"2024012416584404600_ref25","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1523-1755.2002.00503.x","article-title":"Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1","volume":"62","author":"Zoja","year":"2002","journal-title":"Kidney Int"},{"key":"2024012416584404600_ref26","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1182\/blood.V86.12.4553.bloodjournal86124553","article-title":"Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions","volume":"86","author":"Morigi","year":"1995","journal-title":"Blood"},{"key":"2024012416584404600_ref27","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1182\/blood.V98.6.1828","article-title":"Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress","volume":"98","author":"Morigi","year":"2001","journal-title":"Blood"},{"key":"2024012416584404600_ref28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1172\/JCI57313","article-title":"The CXCR4\/CXCR7\/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice","volume":"122","author":"Petruzziello-Pellegrini","year":"2012","journal-title":"J Clin Invest"},{"key":"2024012416584404600_ref29","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.4049\/jimmunol.170.4.2074","article-title":"Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli","volume":"170","author":"Hauf","year":"2003","journal-title":"J Immunol"},{"key":"2024012416584404600_ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8858","article-title":"Flow-driven assembly of VWF fibres and webs in in vitro microvessels","volume":"6","author":"Zheng","year":"2015","journal-title":"Nat Commun"},{"key":"2024012416584404600_ref31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10096-007-0420-3","article-title":"Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157","volume":"27","author":"Kawano","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024012416584404600_ref32","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1016\/S0021-9258(19)67839-7","article-title":"Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function","volume":"266","author":"Head","year":"1991","journal-title":"J Biol Chem"},{"key":"2024012416584404600_ref33","doi-asserted-by":"crossref","first-page":"e1801120","DOI":"10.1002\/adhm.201801120","article-title":"Reconstructing the human renal vascular-tubular unit in vitro","volume":"7","author":"Rayner","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"2024012416584404600_ref34","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/nar\/18.12.3587","article-title":"Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line","volume":"18","author":"Morgenstern","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"2024012416584404600_ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-018-2486-6","article-title":"iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data","volume":"19","author":"Ge","year":"2018","journal-title":"BMC Bioinf"}],"container-title":["Integrative Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ib\/article-pdf\/doi\/10.1093\/intbio\/zyae001\/56338993\/zyae001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ib\/article-pdf\/doi\/10.1093\/intbio\/zyae001\/56338993\/zyae001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T16:59:13Z","timestamp":1706115553000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ib\/article\/doi\/10.1093\/intbio\/zyae001\/7585571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1093\/intbio\/zyae001","relation":{},"ISSN":["1757-9708"],"issn-type":[{"value":"1757-9708","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024]]},"published":{"date-parts":[[2024]]},"article-number":"zyae001"}}